$35M Series C Fuels Octave’s Commercial Momentum in Precision Neurology – Read the Release

Contact Us

Clinical validation of a multi-protein, serum-based assay for disease activity assessments in multiple sclerosis

August 30, 2023inByCommentNo Comments
Click here